Search

everythinglearnresearchcommunity

for

Search:↓

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

Premature graying of hair is linked to vitamin D and B12 deficiencies, thyroid issues, iron imbalance, stress, and lifestyle habits, and affects quality of life.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

Low androgen levels can still cause female pattern hair loss.

Inositol was more effective than Metformin in treating symptoms of PCOS in women.

Exercise and finasteride together improve ovary health in PCOS rats.

Low zinc levels may contribute to hair loss due to increased oxidative DNA damage.

Low zinc and selenium levels in sheep are linked to hair loss and thyroid problems.

People with lower levels of free testosterone tend to have worse COVID-19 outcomes.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Higher BPA levels may be linked to idiopathic hyperandrogenemia in women.

Nandrolone might increase muscle mass with fewer side effects than testosterone but could cause erectile dysfunction and needs more research.

Centratherum anthelminticum seed extract effectively treats Polycystic Ovary Syndrome in rats.

Pregnant women with Systemic Lupus Erythematosus have a higher risk of blood clotting problems.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

AMH levels can't reliably tell the difference between LOCAH and all types of PCOS in women with excessive hair growth.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Scientists developed a method to grow human fetal skin and digits in a lab for 3-4 weeks, which could help study skin features and understand genetic interactions in tissue formation.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

Injecting vitamin D3 into the skin is an effective treatment for patchy hair loss.

Vitamin D levels do not significantly relate to the causes of PCOS or DOR in infertile patients.

A genetic defect in vitamin D receptors causes severe rickets and hair loss in children, but some heal as they age.

Ashwagandha may improve hormone levels and reduce hair loss in non-classical adrenal hyperplasia.

Certain gene variations in AKT2 are more common in women with PCOS and are linked to higher levels of specific hormones and symptoms.

An 84-year-old woman's hair loss was due to a rare condition called Leydig cell hyperplasia, which was treated with surgery.